|
| 36805958 | Tumor and Stromal Cell Targeting with Nintedanib and Alpelisib Overcomes Intrinsic Bladder Cancer Resistance. | Mol Cancer Ther | 2023 |
| 37588099 | Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological features. | Front Oncol | 2023 |
| 37353485 | NFIC regulates ribosomal biology and ER stress in pancreatic acinar cells and restrains PDAC initiation. | Nat Commun | 2023 |
| 37351909 | Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. | Cancer Epidemiol Biomarkers Prev | 2023 |
| 37210288 | Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights. | Eur Urol | 2023 |
| 37477495 | Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection. | Cancer Prev Res (Phila) | 2023 |
| 36890105 | Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities. | Eur Urol Oncol | 2023 |
| 36519825 | Pseudoalignment tools as an efficient alternative to detect repeated transposable elements in scRNAseq data. | Bioinformatics | 2023 |
| 35260444 | A faecal microbiota signature with high specificity for pancreatic cancer. | Gut | 2022 |
| 35420133 | Natural killer cells act as an extrinsic barrier for in vivo reprogramming. | Development | 2022 |
| 36270281 | Deciphering the roadmap of in vivo reprogramming toward pluripotency. | Stem Cell Reports | 2022 |
| 36085102 | BlaDimiR: A Urine-based miRNA Score for Accurate Bladder Cancer Diagnosis and Follow-up. | Eur Urol | 2022 |
| 33846140 | A GATA6-centred gene regulatory network involving HNFs and οNp63 controls plasticity and immune escape in pancreatic cancer. | Gut | 2022 |
| 35338084 | Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors. | J Immunother Cancer | 2022 |
| 32409590 | Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses. | Gut | 2021 |
| 33654171 | Publisher Correction: Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice. | Sci Rep | 2021 |
| 33863885 | An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. | Nat Commun | 2021 |
| 34926472 | Cell Lineage Infidelity in PDAC Progression and Therapy Resistance. | Front Cell Dev Biol | 2021 |
| 34648034 | STAG2 loss-of-function affects short-range genomic contacts and modulates the basal-luminal transcriptional program of bladder cancer cells. | Nucleic Acids Res | 2021 |
| 34545020 | Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study. | Eur J Cancer Prev | 2021 |
| 34330784 | Discovery and 3D imaging of a novel οNp63-expressing basal cell type in human pancreatic ducts with implications in disease. | Gut | 2021 |
| 33227409 | Pancreatic cancer transcriptomes: molecular stratification in the adjuvant setting. | Ann Oncol | 2021 |
| 33079429 | Epithelial Nr5a2 heterozygosity cooperates with mutant Kras in the development of pancreatic cystic lesions. | J Pathol | 2021 |
| 33411965 | Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma. | Int J Cancer | 2021 |
| 31306552 | Vitamin D differentially regulates colon stem cells in patient-derived normal and tumor organoids. | FEBS J | 2020 |
| 31875961 | Loss of GATA4 causes ectopic pancreas in the stomach. | J Pathol | 2020 |
| 32051190 | Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 32037144 | Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5. | Eur Urol | 2020 |
| 31911549 | Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features. | Cancer Res | 2020 |
| 33110094 | Pancreatic duct ligation reduces premalignant pancreatic lesions in a Kras model of pancreatic adenocarcinoma in mice. | Sci Rep | 2020 |
| 32635360 | Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy. | Cancers (Basel) | 2020 |
| 32682615 | FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?<sup>â¿ </sup>. | Eur Urol | 2020 |
| 32587399 | The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driver. | Oncogene | 2020 |
| 32783938 | Essential Roles of Cohesin STAG2 in Mouse Embryonic Development and Adult Tissue Homeostasis. | Cell Rep | 2020 |
| 32641412 | Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. | Cancer Res | 2020 |
| 32154941 | HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer. | EMBO J | 2020 |
| 32451433 | Bptf determines oncogenic addiction in aggressive B-cell lymphomas. | Oncogene | 2020 |
| 29158237 | Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations. | Gut | 2019 |
| 30242024 | CDK4/6 Inhibitor as a Novel Therapeutic Approach for Advanced Bladder Cancer Independently of <i>RB1</i> Status. | Clin Cancer Res | 2019 |
| 30229903 | Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case-control approaches. | Int J Cancer | 2019 |
| 31562298 | Urothelial organoids originating from Cd49f<sup>high</sup> mouse stem cells display Notch-dependent differentiation capacity. | Nat Commun | 2019 |
| 30898261 | Mouse Models Shed Light on the SLIT/ROBO Pathway in Pancreatic Development and Cancer. | Trends Cancer | 2019 |
| 30541042 | Agnostic Pathway/Gene Set Analysis of Genome-Wide Association Data Identifies Associations for Pancreatic Cancer. | J Natl Cancer Inst | 2019 |
| 30514911 | Reply to 'Mosaic loss of chromosome Y in leukocytes matters'. | Nat Genet | 2019 |
| 28754779 | Genome-wide association study identifies inversion in the <i>CTRB1-CTRB2</i> locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis. | Gut | 2018 |
| 29860982 | Mutant Kras Dosage and Chromothripsis: The Right Ingredients for a Pancreatic Cancer Catastrophe. | Trends Cancer | 2018 |
| 28159836 | c-Myc downregulation is required for preacinar to acinar maturation and pancreatic homeostasis. | Gut | 2018 |
| 29422604 | Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. | Nat Commun | 2018 |
| 29443959 | Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas. | Nature | 2018 |
| 29661802 | Genetic unrelatedness of co-occurring pancreatic adenocarcinomas and IPMNs challenges current views of clinical management. | Gut | 2018 |